High bone mass associated with berardinelli lipodystrophy

Endocrine Practice

Volumn 13, Issue 7, 2007, Pages 764-769

  Bandeira, Francisco F ^a   Miranda, Clelia Rocha ^a   Waechter, Cynthia ^a   Bandeira, Maria Elba ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; HUMAN GROWTH HORMONE; INSULIN; LACTATE DEHYDROGENASE; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BLOOD; BODY COMPOSITION; BONE DENSITY; CASE REPORT; CONGENITAL GENERALIZED LIPODYSTROPHY; DEHYDRATION; ECHOGRAPHY; FATIGUE; FATTY LIVER; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY;

ADOLESCENT; BODY COMPOSITION; BONE DENSITY; CREATINE KINASE; DEHYDRATION; FATIGUE; FATTY LIVER; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPERGLYCEMIA; HYPERNATREMIA; INSULIN; INSULIN-LIKE GROWTH FACTOR I; L-LACTATE DEHYDROGENASE; LIPODYSTROPHY, CONGENITAL GENERALIZED; MAGNETIC RESONANCE IMAGING;

EID: 38949089813     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.13.7.764     Document Type: Article

References (17)

1. Simha V, Garg A. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes. J Clin Endocrinol Metab. 2003;88:5433-5437.
2. Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350:1220-1234.
3. Rajab A, Khaburi M, Spranger S, Kunze J, Spranger J. Congenital generalized lipodystrophy, mental retardation, deafness, short stature, and slender bones: a newly recognized syndrome? Am J Med Genet A. 2003;121:271-276.
4. Elefteriou F, Takeda S, Ebihara K, et al. Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A. 2004;101:3258-3263.
5. Zborowski JV, Cauley JA, Talbott EO, Guzick DS, Winters SJ. Clinical review 116: bone mineral density, androgens, and the polycystic ovary; the complex and controversial issue of androgenic influence in female bone. J Clin Endocrinol Metab. 2000;85:3496-3506.
6. van Daele PL, Stolk RP, Burger H, et al. Bone density in non-insulin-dependent diabetes mellitus: the Rotterdam Study. Ann Intern Med. 1995;122:409-414.
7. Moyer-Mileur LJ, Dixon SB, Quick JL, Askew EW, Murray MA. Bone mineral acquisition in adolescents with type 1 diabetes. J Pediatr. 2004;145:662-669.
8. Heap J, Murray MA, Miller SC, Jalili T, Moyer-Mileur LJ. Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus. J Pediatr. 2004;144:56-62.
9. Whitfield JF. Leptin: brains and bones. Exp Opin Investig Drugs. 2001;10:1617-1622.
10. Thomas T, Burguera B, Melton LJ III, et al. Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone. 2001;29:114-120.
11. Nagy Z, Speer G, Takács I, Bajnok È, Lakatos P. Serum leptin levels and bone mineral density in postmenopausal women [abstract]. J Bone Miner Res. 2001;16(Suppl 1):S284.
12. Stolk RP, Van Daele PL, Pols HA, et al. Hyperinsulinemia and bone mineral density in an elderly population: the Rotterdam Study [erratum in Bone. 1996;19:566]. Bone. 1996;18:545-549.
13. Barret-Connor E, Kritz-Silverstein D. Does hyperinsulinemia preserve bone? Diabetes Care. 1996;19:1388-1392.
14. Nestler JE, Powers LP, Matt DW, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72:83-89.
15. Cokolic M. Diabetes mellitus and osteoporosis. Diabetologia Croatica. 1998;27:135-142.
16. Cornish J, Callon KE, Reid IR. Insulin increases histomorphometric indices of bone formation in vivo. Calcif Tissue Int. 1996;59:492-495.
17. Hock JM, Centrella M, Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology. 1988;122:254-260.